行情

XBIT

XBIT

XBiotech
NASDAQ

实时行情|Nasdaq Last Sale

24.30
-0.60
-2.39%
盘后: 24.50 +0.2 +0.80% 17:18 01/17 EST
开盘
24.93
昨收
24.90
最高
25.00
最低
23.78
成交量
131.52万
成交额
--
52周最高
26.40
52周最低
5.22
市值
9.98亿
市盈率(TTM)
-37.9984
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

XBIT 新闻

  • 沪指震荡上扬 中国央行4天投放1.1万亿
  • 新浪财经.41分钟前
  • 英媒刊文:生产率下滑正困扰新兴经济体
  • 参考消息.4小时前
  • 戈恩为何决定逃亡?日媒揭秘:或因听闻审理将延期
  • 中国新闻网.4小时前
  • 日媒:戈恩从日本逃往黎巴嫩或因听闻审理将延期
  • 新京报网.4小时前

更多

所属板块

生物技术和医学研究
-0.16%
制药与医学研究
+0.06%

热门股票

名称
价格
涨跌幅

XBIT 简况

XBiotech Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing True Human monoclonal antibodies for treating a range of different diseases. It focuses on its lead product candidate, Xilonix (MABp1), which is derived from a natural human immune response. The Company has also developed a True Human monoclonal antibody discovery platform and manufacturing system. Xilonix is a therapeutic antibody, which specifically neutralizes interleukin-1 alpha (IL-1a). Its pipeline includes various human antibodies for treating diseases, such as cancer, vascular disease, inflammatory skin disease and diabetes. The Company has completed a Phase III study in Europe for the treatment of symptomatic colorectal cancer. It also investigated its lead product candidate in clinical trials for other inflammatory conditions, including vascular disease, type II diabetes, acne, psoriasis, pyoderma gangrenosum (PG) and hidradenitis suppurativa (HS).
展开

Webull提供XBiotech Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。